Modified Glasgow prognostic score

https://www.mdcalc.com/modified-glasgow-prognostic-score-mgps-cancer-outcomes

The modified Glasgow prognostic score (mGPS), a combination of C-reactive protein (CRP) and albumin levels, reflects systemic inflammation and nutritional status. This score has been shown to have a prognosis value for various tumors.

pre-radiosurgical mGPS and Neutrophil-to-Lymphocyte Ratio (NLR) groups seem to be the most effective and simple independent prognostic factors to predict clinical outcome in radiosurgically treated BM patients 1)

Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), Lymphocyte-to-Monocyte Ratio (LMR) and mGPS represent effective and simple tools to predict survival in NSCLC patients prior to radiosurgery for brain metastases 2)

1)
Cho A, Untersteiner H, Fitschek F, Khalaveh F, Pruckner P, Pavo N, Rössler K, Dorfer C, Gatterbauer B, Höller C, Schmidinger M, Frischer JM. The clinical relevance of laboratory prognostic scores for patients with radiosurgically treated brain metastases of non-pulmonary primary tumor. J Neurooncol. 2021 Jun 20. doi: 10.1007/s11060-021-03788-6. Epub ahead of print. PMID: 34148164.
2)
Cho A, Untersteiner H, Hirschmann D, Fitschek F, Dorfer C, Rössler K, Zöchbauer-Müller S, Gatterbauer B, Hochmair MJ, Frischer JM. Pre-radiosurgery leucocyte ratios and modified glasgow prognostic score predict survival in non- small cell lung cancer brain metastases patients. J Neurooncol. 2021 Jan;151(2):257-265. doi: 10.1007/s11060-020-03660-z. Epub 2020 Nov 11. PMID: 33179214; PMCID: PMC7875838.